Hypoxia-induced SUMOylation of E3 ligase HAF determines specific activation of HIF2 in clear-cell renal cell carcinoma

Mei Yee Koh, Vuvi Nguyen, Robert Lemos, Bryant G. Darnay, Galina Kiriakova, Mena Abdelmelek, Thai H Ho, Jose Karam, Federico A. Monzon, Eric Jonasch, Garth Powis

Research output: Contribution to journalArticle

19 Citations (Scopus)

Abstract

Clear-cell renal cell cancer (CRCC) is initiated typically by loss of the tumor-suppressor VHL, driving constitutive activation of hypoxia-inducible factor-1 (HIF1) and HIF2. However, whereas HIF1 has a tumor-suppressor role, HIF2 plays a distinct role in driving CRCC. In this study, we show that the HIF1α E3 ligase hypoxia-associated factor (HAF) complexes with HIF2α at DNA to promote HIF2-dependent transcription through a mechanism relying upon HAF SUMOylation. HAF SUMOylation was induced by hypoxia, whereas HAF-mediated HIF1α degradation was SUMOylation independent. HAF overexpression in mice increased CRCC growth and metastasis. Clinically, HAF overexpression was associated with poor prognosis. Taken together, our results show that HAF is a specific mediator of HIF2 activation that is critical for CRCC development and morbidity.

Original languageEnglish (US)
Pages (from-to)316-329
Number of pages14
JournalCancer Research
Volume75
Issue number2
DOIs
StatePublished - Aug 8 2015

Fingerprint

Sumoylation
Ubiquitin-Protein Ligases
Renal Cell Carcinoma
Hypoxia-Inducible Factor 1
Hypoxia
Neoplasms
Neoplasm Metastasis
Morbidity
DNA

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Koh, M. Y., Nguyen, V., Lemos, R., Darnay, B. G., Kiriakova, G., Abdelmelek, M., ... Powis, G. (2015). Hypoxia-induced SUMOylation of E3 ligase HAF determines specific activation of HIF2 in clear-cell renal cell carcinoma. Cancer Research, 75(2), 316-329. https://doi.org/10.1158/0008-5472.CAN-13-2190

Hypoxia-induced SUMOylation of E3 ligase HAF determines specific activation of HIF2 in clear-cell renal cell carcinoma. / Koh, Mei Yee; Nguyen, Vuvi; Lemos, Robert; Darnay, Bryant G.; Kiriakova, Galina; Abdelmelek, Mena; Ho, Thai H; Karam, Jose; Monzon, Federico A.; Jonasch, Eric; Powis, Garth.

In: Cancer Research, Vol. 75, No. 2, 08.08.2015, p. 316-329.

Research output: Contribution to journalArticle

Koh, MY, Nguyen, V, Lemos, R, Darnay, BG, Kiriakova, G, Abdelmelek, M, Ho, TH, Karam, J, Monzon, FA, Jonasch, E & Powis, G 2015, 'Hypoxia-induced SUMOylation of E3 ligase HAF determines specific activation of HIF2 in clear-cell renal cell carcinoma', Cancer Research, vol. 75, no. 2, pp. 316-329. https://doi.org/10.1158/0008-5472.CAN-13-2190
Koh, Mei Yee ; Nguyen, Vuvi ; Lemos, Robert ; Darnay, Bryant G. ; Kiriakova, Galina ; Abdelmelek, Mena ; Ho, Thai H ; Karam, Jose ; Monzon, Federico A. ; Jonasch, Eric ; Powis, Garth. / Hypoxia-induced SUMOylation of E3 ligase HAF determines specific activation of HIF2 in clear-cell renal cell carcinoma. In: Cancer Research. 2015 ; Vol. 75, No. 2. pp. 316-329.
@article{62ba715b5dbb4328856c88ff348af249,
title = "Hypoxia-induced SUMOylation of E3 ligase HAF determines specific activation of HIF2 in clear-cell renal cell carcinoma",
abstract = "Clear-cell renal cell cancer (CRCC) is initiated typically by loss of the tumor-suppressor VHL, driving constitutive activation of hypoxia-inducible factor-1 (HIF1) and HIF2. However, whereas HIF1 has a tumor-suppressor role, HIF2 plays a distinct role in driving CRCC. In this study, we show that the HIF1α E3 ligase hypoxia-associated factor (HAF) complexes with HIF2α at DNA to promote HIF2-dependent transcription through a mechanism relying upon HAF SUMOylation. HAF SUMOylation was induced by hypoxia, whereas HAF-mediated HIF1α degradation was SUMOylation independent. HAF overexpression in mice increased CRCC growth and metastasis. Clinically, HAF overexpression was associated with poor prognosis. Taken together, our results show that HAF is a specific mediator of HIF2 activation that is critical for CRCC development and morbidity.",
author = "Koh, {Mei Yee} and Vuvi Nguyen and Robert Lemos and Darnay, {Bryant G.} and Galina Kiriakova and Mena Abdelmelek and Ho, {Thai H} and Jose Karam and Monzon, {Federico A.} and Eric Jonasch and Garth Powis",
year = "2015",
month = "8",
day = "8",
doi = "10.1158/0008-5472.CAN-13-2190",
language = "English (US)",
volume = "75",
pages = "316--329",
journal = "Journal of Cancer Research",
issn = "0099-7013",
publisher = "American Association for Cancer Research Inc.",
number = "2",

}

TY - JOUR

T1 - Hypoxia-induced SUMOylation of E3 ligase HAF determines specific activation of HIF2 in clear-cell renal cell carcinoma

AU - Koh, Mei Yee

AU - Nguyen, Vuvi

AU - Lemos, Robert

AU - Darnay, Bryant G.

AU - Kiriakova, Galina

AU - Abdelmelek, Mena

AU - Ho, Thai H

AU - Karam, Jose

AU - Monzon, Federico A.

AU - Jonasch, Eric

AU - Powis, Garth

PY - 2015/8/8

Y1 - 2015/8/8

N2 - Clear-cell renal cell cancer (CRCC) is initiated typically by loss of the tumor-suppressor VHL, driving constitutive activation of hypoxia-inducible factor-1 (HIF1) and HIF2. However, whereas HIF1 has a tumor-suppressor role, HIF2 plays a distinct role in driving CRCC. In this study, we show that the HIF1α E3 ligase hypoxia-associated factor (HAF) complexes with HIF2α at DNA to promote HIF2-dependent transcription through a mechanism relying upon HAF SUMOylation. HAF SUMOylation was induced by hypoxia, whereas HAF-mediated HIF1α degradation was SUMOylation independent. HAF overexpression in mice increased CRCC growth and metastasis. Clinically, HAF overexpression was associated with poor prognosis. Taken together, our results show that HAF is a specific mediator of HIF2 activation that is critical for CRCC development and morbidity.

AB - Clear-cell renal cell cancer (CRCC) is initiated typically by loss of the tumor-suppressor VHL, driving constitutive activation of hypoxia-inducible factor-1 (HIF1) and HIF2. However, whereas HIF1 has a tumor-suppressor role, HIF2 plays a distinct role in driving CRCC. In this study, we show that the HIF1α E3 ligase hypoxia-associated factor (HAF) complexes with HIF2α at DNA to promote HIF2-dependent transcription through a mechanism relying upon HAF SUMOylation. HAF SUMOylation was induced by hypoxia, whereas HAF-mediated HIF1α degradation was SUMOylation independent. HAF overexpression in mice increased CRCC growth and metastasis. Clinically, HAF overexpression was associated with poor prognosis. Taken together, our results show that HAF is a specific mediator of HIF2 activation that is critical for CRCC development and morbidity.

UR - http://www.scopus.com/inward/record.url?scp=84921031257&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84921031257&partnerID=8YFLogxK

U2 - 10.1158/0008-5472.CAN-13-2190

DO - 10.1158/0008-5472.CAN-13-2190

M3 - Article

C2 - 25421578

AN - SCOPUS:84921031257

VL - 75

SP - 316

EP - 329

JO - Journal of Cancer Research

JF - Journal of Cancer Research

SN - 0099-7013

IS - 2

ER -